| Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up H Tilly, MG Da Silva, U Vitolo, A Jack, M Meignan, A Lopez-Guillermo, ... Annals of oncology 26, v116-v125, 2015 | 1098 | 2015 |
| Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆ M Dreyling, M Ghielmini, S Rule, G Salles, M Ladetto, SH Tonino, ... Annals of Oncology 32 (3), 298-308, 2021 | 920* | 2021 |
| MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ... Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008 | 755 | 2008 |
| Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up DA Eichenauer, BMP Aleman, M André, M Federico, M Hutchings, ... Annals of Oncology 29, iv19-iv29, 2018 | 600* | 2018 |
| Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ... The Lancet Haematology 7 (10), e737-e745, 2020 | 559 | 2020 |
| ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma M Dreyling, C Thieblemont, A Gallamini, L Arcaini, E Campo, O Hermine, ... Annals of Oncology 24 (4), 857-877, 2013 | 359 | 2013 |
| Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders M Ladetto, M Brüggemann, L Monitillo, S Ferrero, F Pepin, D Drandi, ... Leukemia 28 (6), 1299-1307, 2014 | 349 | 2014 |
| Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma M Ladetto, G Pagliano, S Ferrero, F Cavallo, D Drandi, L Santo, C Crippa, ... Journal of Clinical Oncology 28 (12), 2077-2084, 2010 | 341 | 2010 |
| Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells P Corradini, C Voena, C Tarella, M Astolfi, M Ladetto, A Palumbo, ... Journal of Clinical Oncology 17 (1), 208-208, 1999 | 307 | 1999 |
| Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis … M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti, A Rambaldi, ... Blood, The Journal of the American Society of Hematology 111 (8), 4004-4013, 2008 | 296 | 2008 |
| Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ... Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013 | 290 | 2013 |
| Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP P Pregno, A Chiappella, M Bellò, B Botto, S Ferrero, S Franceschetti, ... Blood, The Journal of the American Society of Hematology 119 (9), 2066-2073, 2012 | 286 | 2012 |
| Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰ E Zucca, L Arcaini, C Buske, PW Johnson, M Ponzoni, M Raderer, ... Annals of oncology 31 (1), 17-29, 2020 | 276 | 2020 |
| Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up DA Eichenauer, A Engert, M André, M Federico, T Illidge, M Hutchings, ... Annals of oncology 25, iii70-iii75, 2014 | 276 | 2014 |
| Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ... Clinical Cancer Research 15 (13), 4415-4422, 2009 | 255 | 2009 |
| ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ... Annals of Oncology 24 (3), 561-576, 2013 | 254 | 2013 |
| Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Zucca, C Copie-Bergman, U Ricardi, C Thieblemont, M Raderer, ... Annals of Oncology 24, vi144-vi148, 2013 | 253 | 2013 |
| Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up R Willemze, E Hodak, PL Zinzani, L Specht, M Ladetto Annals of Oncology 29, iv30-iv40, 2018 | 238 | 2018 |
| Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, ... Nature medicine 6 (6), 667-672, 2000 | 221 | 2000 |
| Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial U Vitolo, A Chiappella, S Franceschetti, AM Carella, I Baldi, G Inghirami, ... The Lancet Oncology 15 (7), 730-737, 2014 | 218* | 2014 |
